Sign in

CIK 0001520262 · Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981007018
Phone
00-353-1-772-8000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,070,874
in 5 filings, $1.1M under 10b5-1 plans

Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hopkinson Craig C. −$423K EVP R&D, Chief Medical Officer sold 12% of stake
  2. Nichols Christian Todd −$373K SVP, Chief Commercial Officer sold 7% of stake
  3. Gaffin David Joseph −$275K EVP, CLO, Alkermes, Inc. sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-12-02 Cooke Shane Director Option exercise +5,578 93,379
2021-12-02 Cooke Shane Director Shares withheld for taxes −2,901 $22.11 $64K 90,478
2021-12-02 Cooke Shane Director Option exercise · Restricted Stock Unit Award −5,578 0
2021-09-14 POPS RICHARD F Director and CEO, Alkermes plc Grant or award +81,682 873,722
2021-09-14 POPS RICHARD F Director and CEO, Alkermes plc Shares withheld for taxes −36,267 $30.60 $1.1M 837,455
2021-09-14 Nichols Christian Todd SVP, Chief Commercial Officer Grant or award +15,672 23,146
2021-09-14 Nichols Christian Todd SVP, Chief Commercial Officer Shares withheld for taxes −4,608 $30.60 $141K 18,538
2021-09-14 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Grant or award +8,031 224,812
2021-09-14 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Shares withheld for taxes −3,566 $30.60 $109K 221,246
2021-09-14 Jackson Blair Curtis EVP, Chief Operating Officer Grant or award +6,884 75,038
2021-09-14 Jackson Blair Curtis EVP, Chief Operating Officer Shares withheld for taxes −2,024 $30.60 $62K 73,014
2021-09-14 Hopkinson Craig C. EVP R&D, Chief Medical Officer Grant or award +15,143 15,143
2021-09-14 Hopkinson Craig C. EVP R&D, Chief Medical Officer Shares withheld for taxes −5,647 $30.60 $173K 9,496
2021-09-14 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Grant or award +10,555 85,152
2021-09-14 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Shares withheld for taxes −4,634 $30.60 $142K 80,518
2021-09-14 Brown Iain Michael SVP, Chief Financial Officer Grant or award +6,884 49,864
2021-09-14 Brown Iain Michael SVP, Chief Financial Officer Shares withheld for taxes −3,057 $30.60 $94K 46,807
2021-08-23 Alva Emily Peterson Director Purchase +1,650.17 $30.22 $50K 1,650.17
2021-08-19 Brown Iain Michael SVP, Chief Financial Officer Option exercise +40,000 $16.55 $662K 82,980
2021-08-19 Brown Iain Michael SVP, Chief Financial Officer Sale −40,000 $29.99 $1.2M 42,980

Page 59 of 60 · 1,194 trades